Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 11.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1998 to 2007

Recipients with Heart Transplants

  Year of Transplant
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
Transplants 2,348 2,188 2,199 2,202 2,155 2,057 2,015 2,125 2,193 2,209
Tx with Follow-up Immunosuppression Info 1,933 1,768 1,811 1,848 1,817 1,733 1,741 1,802 1,891 1,899
Corticosteroids Any in Category 89.9% 92.5% 92.2% 90.7% 88.3% 85.4% 89.8% 89.7% 88.9% 85.5%
Steroids 89.9% 92.5% 92.2% 90.7% 88.3% 85.4% 89.8% 89.7% 88.9% 85.5%
Cyclosporine Any in Category 78.5% 81.0% 76.8% 63.9% 56.9% 53.4% 49.1% 40.9% 38.0% 32.7%
Cyclosporin 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.1% 0.6% 1.3% 1.3%
Sandimmmune 10.3% 7.9% 5.5% 3.4% 2.0% 1.2% 1.3% 1.5% 1.8% 1.2%
Neoral 68.1% 73.0% 67.1% 50.3% 42.0% 38.2% 32.7% 27.1% 26.0% 23.5%
Gengraf 0.0% 0.0% 4.1% 9.7% 12.4% 13.4% 14.7% 11.3% 8.7% 6.4%
Eon 0.0% 0.1% 0.1% 0.3% 0.4% 0.6% 0.3% 0.4% 0.2% 0.4%
Tacrolimus Any in Category 24.4% 27.1% 30.6% 43.3% 50.0% 53.1% 57.0% 64.7% 67.5% 71.9%
Tacrolimus 24.4% 27.1% 30.6% 43.3% 50.0% 53.1% 57.0% 64.7% 67.1% 71.5%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.4% 0.4%
Antimetabolites Any in Category 90.9% 86.4% 90.9% 89.2% 87.4% 87.9% 94.4% 94.7% 92.6% 92.8%
Mycophenolate Mofetil 56.2% 57.5% 72.0% 74.8% 74.2% 78.1% 84.0% 82.5% 82.2% 81.1%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.8% 0.3% 0.2% 2.7% 2.9% 5.0%
Azathioprine 34.2% 28.6% 18.7% 14.3% 12.3% 9.5% 10.2% 9.4% 7.3% 6.6%
Leflunomide 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.1% 0.2% 0.1%
Cytoxan 0.6% 0.3% 0.2% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.4% 3.2% 5.0% 7.4% 14.3% 16.4% 12.7% 11.0% 10.7% 10.4%
Sirolimus 0.4% 2.1% 4.7% 7.4% 14.3% 16.4% 12.6% 10.7% 8.7% 7.4%
Everolimus 0.1% 1.0% 0.3% 0.0% 0.0% 0.0% 0.1% 0.4% 2.0% 2.9%


Source: OPTN/SRTR Data as of May 4, 2009.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.



PDF FormatRequires Adobe Acrobat Reader